(E1)levating COVID-19 vaccine efficiency with adenoviral E1 proteins.
Douglas R GreenPaul Glyndwr ThomasPublished in: Science advances (2022)
Improved adenovirus-based COVID-19 vaccines provide an important tool to combat the ever-evolving virus.
Keyphrases